Enzymatic pathways, glycosaminoglycan degradation |
Abubucker et al., 2012; Koppel et al., 2017
|
Energy metabolism (short chain fatty acids, glucose) |
den Besten et al., 2013; Hartstra et al., 2015; Sonnenburg and Bäckhed, 2016
|
Neurotransmitter production |
O’Mahony et al., 2015; Yano et al., 2015; Savidge, 2016
|
Vitamin absorption |
Magnúsdóttir et al., 2015 |
Regulation of bile acid metabolism, (deoxycholic and lithocholic acids, bile salts) |
Fiorucci and Distrutti, 2015; Weiss and Hennet, 2017
|
Endocrine and gut hormone regulation |
Neuman et al., 2015; Fukui et al., 2018
|
Adaptive immunity, mucosal and systemic immunity |
Thaiss et al., 2016; Desselberger, 2018
|
Cell proliferation, mucosal barrier protection, inflammation |
Morgan et al., 2012; Blander et al., 2017; Schirmer et al., 2018
|
Protection against pathogens |
Zeng et al., 2016; Zhang et al., 2018
|
Vascularization, tri-ethylamine associated atherosclerosis, tri-ethylamine N-oxide (TMAO) production |
Karlsson et al., 2012; Tang et al., 2013; Tang and Hazen, 2014
|
Bone mass |
McCabe et al., 2015; Yan et al., 2016
|
Appetite signaling, obesity |
Hentzer and Givskov, 2003; Ley et al., 2006
|
Metabolic transformation of xenobiotics (small molecules foreign to the body) |
Koppel et al., 2017 |
|